Benzinga | May 17, 2021 06:12AM EDT

HC Wainwright & Co. Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $212

HC Wainwright & Co. analyst Oren Livnat maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $207 to $212.